THELMA Therapeutics Past Earnings Performance
Past criteria checks 0/6
THELMA Therapeutics has been growing earnings at an average annual rate of 16.4%, while the Media industry saw earnings growing at 6.2% annually. Revenues have been declining at an average rate of 40.6% per year.
Key information
16.4%
Earnings growth rate
31.4%
EPS growth rate
| Media Industry Growth | 6.2% |
| Revenue growth rate | -40.6% |
| Return on equity | -14.7% |
| Net Margin | -51.7% |
| Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How THELMA Therapeutics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 23 | 6,507 | -3,363 | 4,051 | 0 |
| 31 Mar 23 | 7,158 | -3,932 | 3,655 | 0 |
| 31 Dec 22 | 7,582 | -3,815 | 3,228 | 0 |
| 30 Sep 22 | 7,934 | 3,612 | 7,050 | 0 |
| 30 Jun 22 | 9,492 | 3,226 | 7,529 | 0 |
| 31 Mar 22 | 9,372 | 15 | 11,318 | 50 |
| 31 Dec 21 | 9,568 | -971 | 11,687 | 811 |
| 30 Sep 21 | 6,746 | -32,258 | 31,514 | 1,084 |
| 30 Jun 21 | 7,783 | -35,184 | 32,601 | 1,084 |
| 31 Mar 21 | 7,441 | -36,083 | 29,630 | 1,034 |
| 31 Dec 20 | 7,109 | -35,933 | 30,367 | 273 |
| 30 Sep 20 | 9,684 | -26,328 | 11,188 | 140 |
| 30 Jun 20 | 7,335 | -27,988 | 12,094 | 160 |
| 31 Mar 20 | 8,390 | -27,752 | 12,713 | 216 |
| 31 Dec 19 | 7,742 | -27,808 | 12,420 | 286 |
| 30 Sep 19 | 16,482 | -18,204 | 9,004 | 1,396 |
| 30 Jun 19 | 25,393 | -14,040 | 7,921 | 1,376 |
| 31 Mar 19 | 29,180 | -11,146 | 7,606 | 1,320 |
| 31 Dec 18 | 37,780 | -10,458 | 7,417 | 1,250 |
| 30 Sep 18 | 36,710 | -8,133 | 6,191 | 0 |
| 30 Jun 18 | 42,293 | -8,355 | 6,207 | 0 |
| 31 Mar 18 | 56,222 | -7,767 | 5,872 | 0 |
| 31 Dec 17 | 66,582 | -7,480 | 5,778 | 0 |
| 30 Sep 17 | 74,651 | -9,712 | 6,303 | 0 |
| 30 Jun 17 | 76,467 | -9,018 | 6,253 | 0 |
| 31 Mar 17 | 71,322 | -9,242 | 6,095 | 0 |
| 31 Dec 16 | 69,566 | -10,052 | 6,742 | 0 |
| 30 Sep 16 | 105,271 | -23,410 | 18,215 | 17 |
| 30 Jun 16 | 106,266 | -26,655 | 19,059 | 17 |
| 31 Mar 16 | 90,891 | -24,626 | 17,973 | -45 |
| 31 Dec 15 | 98,223 | -23,734 | 17,513 | 17 |
| 30 Sep 15 | 72,493 | -13,553 | 3,429 | 435 |
| 30 Jun 15 | 84,149 | -9,118 | 1,428 | 543 |
| 31 Mar 15 | 104,765 | -12,360 | 4,039 | 496 |
| 31 Dec 14 | 99,536 | -11,665 | 3,178 | 435 |
| 30 Sep 14 | 92,166 | -4,612 | 4,779 | 0 |
| 30 Jun 14 | 82,817 | -5,159 | 5,054 | -108 |
| 31 Mar 14 | 82,251 | -2,721 | 2,896 | 0 |
| 31 Dec 13 | 87,237 | -2,888 | 3,173 | 0 |
| 30 Sep 13 | 79,612 | -2,842 | -2,594 | 113 |
| 30 Jun 13 | 86,774 | -7,302 | 1,865 | 203 |
| 31 Mar 13 | 94,450 | -8,568 | 2,257 | 407 |
| 31 Dec 12 | 103,312 | -8,585 | 2,248 | 522 |
Quality Earnings: A015540 is currently unprofitable.
Growing Profit Margin: A015540 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A015540 is unprofitable, but has reduced losses over the past 5 years at a rate of 16.4% per year.
Accelerating Growth: Unable to compare A015540's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A015540 is unprofitable, making it difficult to compare its past year earnings growth to the Media industry (-20.2%).
Return on Equity
High ROE: A015540 has a negative Return on Equity (-14.7%), as it is currently unprofitable.